Evidence map›Paper›PMID 38715682›Full record

ArticlePharmacogenomics and personalized medicine2024

Association of the Reduced Function Met420del Polymorphism of SLC22A1 with Metformin-Induced Gastrointestinal Intolerance in Ethiopian Patients with Type 2 Diabetes Mellitus.

Abraham Degaga, Sisay Sirgu, Hasniza Zaman Huri, Maw Shin Sim, Navin Kumar Loganadan, Tedla Kebede, Birhanemeskel Tegene, Ephrem Engidawork, Workineh Shibeshi

Abstract read
In one paragraph

Article in Pharmacogenomics and personalized medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Abraham DegagaDepartment of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Sisay SirguDepartment of Internal Medicine, Diabetes and endocrinology unit, Saint Paul Hospital Millennium Medical College, Addis Ababa, Ethiopia.
Hasniza Zaman HuriDepartment of Clinical Pharmacy & Pharmacy Practice, Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur, Malaysia.
Maw Shin SimDepartment of Pharmaceutical Life Sciences, Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur, Malaysia.
Navin Kumar LoganadanDepartment of Pharmacy, Putrajaya Hospital, Putrajaya, Malaysia.ORCID 0000-0001-6875-8537
Tedla KebedeDepartment of Internal Medicine, Diabetes and endocrinology unit, Addis Ababa University, Addis Ababa, Ethiopia.ORCID 0000-0003-2806-9205
Birhanemeskel TegeneDepartment of Microbiology, Saint Paul Hospital Millennium Medical College, Addis Ababa, Ethiopia.ORCID 0000-0002-0011-2999
Ephrem EngidaworkDepartment of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.ORCID 0000-0002-9931-6421
Workineh ShibeshiDepartment of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.ORCID 0000-0003-3478-6235

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Despite its widespread use and favored profile, there are extensive variations in the treatment outcome of metformin therapy. Furthermore, studies reported that the inter-individual variability in the occurrence of metformin treatment associated side effects were related to the differences in individual genetic profiles. Thus, this study aimed to evaluate whether the reduced function methionine deletion at codon 420 (M Patients and Methods: A retrospective observational study was conducted on 47 T2DM patients on metformin treatment for <3 years to assess the association of Results: In our study, no significant association was observed between rs72552763 and metformin induced gastrointestinal intolerance. We found that the female gender and physical inactivity were risk factors for metformin gastrointestinal intolerance. Conclusion: Our study found that the M

Indexed as

Ethiopiametformin intolerancers72552763SLC22A1 gene

Identifiers

PMID38715682
PMCPMC11075677

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.